{"nct_id":"NCT03256344","title":"Study of Talimogene Laherparepvec With Atezolizumab for Triple Negative Breast Cancer and Colorectal Cancer With Liver Metastases","status":"COMPLETED","status_verified_date":"2024-05","start_date":"2018-03-19","start_date_type":"ACTUAL","primary_completion_date":"2020-05-26","primary_completion_date_type":"ACTUAL","completion_date":"2021-12-03","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["AMGN"]}